1. Catalog
  2. New Options in Platinum Resistant Ovarian Cancer
Image For Activity Cover
New Options in Platinum Resistant Ovarian Cancer
Description
Learn new options for aplatinum resistant FRα positive patient. The webinar reviewed Forward II trial data, discuss MIRV BEV trial data updates, and discuss exciting future options.  

Recorded Tuesday, April 11, 2023
Duration approximately 30 minutes

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.
Faculty Information

David O’Malley, MD
Professor & Director, Division of Gynecologic Oncology
Co-Director, Gyn Oncology Phase I Program
The Ohio State University and the James Cancer Center
Lead Ovarian Cancer Portfolio and PI of Forward 2, GOG Foundation
USA

R. Wendel Naumann, MD
Moderator
Director of Gynecologic Oncology Research
Associate Medical Director of Clinical Trials
Levine Cancer Institute – Hall Gynecologic Oncology Center
Atrium Health
USA
Supported in part by
Summary
Availability: On-Demand
Cost: FREE
Create Account
Recommended
Contact education@igcs.org for assistance.
Powered By